ClinicalTrials.Veeva

Menu

Cardiac Magnetic Resonance in Children With Muscular Dystrophy

C

Cooperative International Neuromuscular Research Group (CINRG)

Status

Completed

Conditions

Becker Muscular Dystrophy
Limb Girdle Muscular Dystrophy
Duchenne Muscular Dystrophy

Study type

Observational

Funder types

NETWORK
NIH

Identifiers

NCT01081080
PITT0110

Details and patient eligibility

About

This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy.

Enrollment

20 estimated patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant enrolled in the CINRG study: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy

Exclusion criteria

  • Pregnant woman (when uncertain, participants will undergo urine testing) or lactating women

  • Decompensated congestive heart failure (unable to lie flat during CMR)

  • Impaired renal excretory function (calculated Glomerular Filtration Rate less than 30mL/min)

  • Contra-indications to Magnetic Resonance Imaging:

    • Cardiac pacemaker or implantable defibrillator
    • Cerebral aneurysm clip
    • Neural stimulator
    • Metallic ocular foreign body
    • Harrington-rod
    • Any implanted device (i.e. insulin pump, drug infusion device)
    • Claustrophobia
    • Metal shrapnel or bullet

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems